The main findings of this study include the following: first, in very old patients with stage 3 CKD, the prevalence of hypertension, beta-blocker use, and NT-proBNP levels increased with the deterioration of renal function, but Hb levels decreased. This evidence concerns the gene GSTM1 and chronic kidney disease.